• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Gilmore O’Neill - Articles and news items

Biogen Idec logo

Biogen Idec and AbbVie announce positive top-line results from Phase 3 study investigating daclizumab high-yield process in multiple sclerosis

Industry news / 16 June 2014 / Biogen Idec

Biogen Idec and AbbVie announced positive top-line results from the Phase 3 DECIDE clinical trial, designed to evaluate the superiority of once-monthly, subcutaneous daclizumab high-yield process…

Biogen Idec logo
Biogen Idec logo

Positive year one results from Biogen Idec Phase 3 ADVANCE trial of PLEGRIDY™ presented at AAN Meeting

Industry news, News / 20 March 2013 / Biogen Idec

“These full first-year results provide a more complete picture of PLEGRIDY…”

Biogen Idec logo

Biogen Idec announces positive top-line results from Phase 3 study of peginterferon beta-1a in multiple sclerosis

Industry news, News / 24 January 2013 / Biogen Idec

Biogen Idec released the primary efficacy analysis and safety data from its Phase 3 pivotal clinical trial…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +